Safety and efficacy of ocrelizumab in rheumatoid arthritis patients with an inadequate response to methotrexate or tumor necrosis factor inhibitors: a systematic review and meta-analysis
Crossref DOI link: https://doi.org/10.1007/s00296-017-3675-8
Published Online: 2017-02-24
Published Print: 2017-07
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Abushouk, Abdelrahman Ibrahim
Ahmed, Hussien
Ismail, Ammar
Elmaraezy, Ahmed
Badr, Ahmed Said
Gadelkarim, Mohamed
Elnenny, Mohammed
License valid from 2017-02-24